<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh">
	<id>https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=AM-2201</id>
	<title>AM-2201 - 版本历史</title>
	<link rel="self" type="application/atom+xml" href="https://arolstar52-zhtest.hf.space/index.php?action=history&amp;feed=atom&amp;title=AM-2201"/>
	<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=AM-2201&amp;action=history"/>
	<updated>2026-07-12T15:44:15Z</updated>
	<subtitle>在这个wiki上该页的修订历史</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://arolstar52-zhtest.hf.space/index.php?title=AM-2201&amp;diff=4631202&amp;oldid=prev</id>
		<title>imported&gt;Jimmy-bot：​机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药</title>
		<link rel="alternate" type="text/html" href="https://arolstar52-zhtest.hf.space/index.php?title=AM-2201&amp;diff=4631202&amp;oldid=prev"/>
		<updated>2025-08-15T10:28:02Z</updated>

		<summary type="html">&lt;p&gt;机器人: 尚未清空的已重定向分类） （&lt;a href=&quot;/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Cat:狡詐家藥物（页面不存在）&quot;&gt;Cat:狡詐家藥物&lt;/a&gt;→&lt;a href=&quot;/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Cat:策划药（页面不存在）&quot;&gt;Cat:策划药&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新页面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Drugbox&lt;br /&gt;
| Verifiedfields = changed&lt;br /&gt;
| Watchedfields = changed&lt;br /&gt;
| verifiedrevid = 451565418&lt;br /&gt;
| IUPAC_name = 1-[(5-Fluoropentyl)-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-indol-3-yl]-(naphthalen-1-yl)methanone&lt;br /&gt;
| image = AM-2201.svg&lt;br /&gt;
| width = 180&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_BR = F2&lt;br /&gt;
| legal_BR_comment = &amp;lt;ref&amp;gt;{{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-07-24 |title=RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |url-status=live |archive-url=https://web.archive.org/web/20230827163149/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451 |archive-date=2023-08-27 |access-date=2023-08-27 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=2023-07-25}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| legal_CA = Schedule II&lt;br /&gt;
| legal_DE = Anlage II&lt;br /&gt;
| legal_UK = Class B&lt;br /&gt;
| legal_US = Schedule I&lt;br /&gt;
| legal_NZ = Temporary Class &lt;br /&gt;
| legal_UN = P II &lt;br /&gt;
| legal_UN_comment = &amp;lt;ref&amp;gt;{{Cite web |title=Substance Details AM-2201 |url=https://www.unodc.org/LSS/Substance/Details/907d3b45-7aa2-41fd-b217-8de909319291 |access-date=2024-01-22}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| legal_status =&lt;br /&gt;
| routes_of_administration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|??}}&lt;br /&gt;
| CAS_number = 335161-24-5&lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| PubChem = 53393997&lt;br /&gt;
| KEGG = C22771&lt;br /&gt;
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}&lt;br /&gt;
| DrugBank = &lt;br /&gt;
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}&lt;br /&gt;
| ChemSpiderID = 24751884&lt;br /&gt;
| UNII_Ref = {{fdacite|changed|FDA}}&lt;br /&gt;
| UNII = TBJ0966F1O&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=24 | H=22 | F=1 | N=1 | O=1&lt;br /&gt;
| smiles = O=C(C1=CN(CCCCCF)C2=C1C=CC=C2)C3=CC=CC4=C3C=CC=C4&lt;br /&gt;
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChI = 1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2&lt;br /&gt;
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}&lt;br /&gt;
| StdInChIKey = ALQFAGFPQCBPED-UHFFFAOYSA-N&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;（化学名：&amp;#039;&amp;#039;&amp;#039;1-(5-氟戊基)-3-(1-萘甲酰基)吲哚&amp;#039;&amp;#039;&amp;#039;，{{lang|en|1-(5-fluoropentyl)-3-(1-naphthoyl)indole}}）是一种[[氮化合物|含氮]][[有机氟化合物]]，分子式[[C24H22FNO|{{chem2|C24H22FNO}}]]，属于[[AM大麻素列表|AM系列大麻素]]，能作为[[大麻素受体]]的完全[[激动剂]]&amp;lt;ref&amp;gt;{{cite journal | title=Bioisosteric Fluorine in the Clandestine Design of Synthetic Cannabinoids | journal=Australian Journal of Chemistry | year=2015 | volume=68 | pages=4–8 | doi=10.1071/CH14198 |  vauthors = Wilkinson SM, Banister, Kassiou M | url=http://www.publish.csiro.au/?paper=CH14198  | issue=1}}&amp;lt;/ref&amp;gt;，由美国[[东北大学_(美国)|东北大学]]的[[亚历山德罗斯·马克里扬尼斯]]研发，为[[JWH-018]]（AM-678）的氟取代衍生物。&lt;br /&gt;
&lt;br /&gt;
==参考文献==&lt;br /&gt;
{{reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:萘甲酰基吲哚]]&lt;br /&gt;
[[Category:有机氟化合物]]&lt;br /&gt;
[[Category:策划药]]&lt;br /&gt;
[[Category:CB1受体激动剂]]&lt;br /&gt;
[[Category:CB2受体激动剂]]&lt;/div&gt;</summary>
		<author><name>imported&gt;Jimmy-bot</name></author>
	</entry>
</feed>